Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity, molecular profiling and safety of Vaxigrip Tetra in adults ≥60 years
2021-003307-18Phase 4Completed
- Sponsor
- University of Antwerp
- Start
- Jun 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quadrivalent influenza vaccine in influenza, sponsored by University of Antwerp. Primary endpoint: HAI antibody titres on Day 0 and Day 28. Started Jun 2021; status: completed.
02
Drugs
quadrivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2021-003307-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-003307-18.